We handed in our ‘Don’t delay funding for vital new drugs and treatments’ petition to NHS England, to urge them to reconsider plans for a new spending cap on treatments. We received an incredible 29,006 signatures, but unfortunately the outcome wasn’t what we hoped for.
Our golf ambassador Bill Elliott knows the Augusta National Golf Club like the back of his hand. While he's been to 35 Masters tournaments, the club, the course and the tournament still get him in a spin. Here we find out why, and who he thinks will stay calm and pull on the coveted Green Jacket in the year’s first major.
While Leicester City's Jamie Vardy was scoring for England against Germany last March, it was a lesser-known James Vardy whose name was on the lips of Jeff Stelling and his Sky Sports colleagues, as he joined them on the Men United March. He tells us why he's walking with Jeff again this year, how his involvement led him to get his own health checked, and the perils of errant Twitter followers every time Jamie Vardy scores.
BLOG: This week we’re actively campaigning in Wales to improve treatment and support for local men.
For many men, the side effects of prostate cancer treatment can be as daunting as the disease itself. Wildlife photographer Gary tells us how the shock of his diagnosis was compounded by fears of incontinence after having surgery, and what he did to give himself the best chance of preventing it.
BLOG: In his latest exclusive blog for Prostate Cancer UK, Jeff Stelling looks forward to being reunited with the extraordinary Kevin Webber, meeting the Green family on the pitch at Exeter City, and pottering with former-England cricketer Dominic Cork in the Potteries.
Charles Packshaw joins us to head up our Board of Trustees after a 30-year career in the City of London. He tells us why the appointment means so much to him personally and how he intends to break his PB at his next cycling fundraiser for us.
Thousands of men could be delayed or denied life-saving new drugs under plans to cap spending by NHS England, prompting "serious concern" and an online petition from leading health and care charities.
BLOG: It's been 12 months since we launched our ambitious plan to halve prostate cancer deaths in a decade, and we’ve already taken some huge steps towards our goal. Our chief executive, Angela Culhane, reflects on the progress we’ve made and the exciting work still to come.
We welcome today's reports of a new test by scientists at the University of East Anglia to determine whether a prostate cancer is aggressive or not, but the tell-tale pattern of 45 specific genes hasn't yet been proven to work for all men.